Haystack is looking forward to attending the ASCO Gastrointestinal Cancers Annual Symposium taking place January 19-21 in San Francisco, CA. ASCO GI will be celebrating 20 years of offering the latest innovative science, solution-focused strategies, and multidisciplinary approaches in GI cancer treatment, research, and care. If you’re there, please stop by table #43 and learn about Haystack’s MRD test that delivers unmatched ctDNA detection sensitivity and accuracy for superior post-surgical treatment management.
Two leading oncologists take a deep dive into how groundbreaking advancements are providing a clearer crystal ball for guiding patient care
January 21, 2025
Oncologists like Dr Doug Flora and Dr Debra Pratt are realists. But when they began to use new tools to find cancer that surgery or treatment might have missed, something exciting happened. “The key is, MRD (minimal residual disease testing)
